Expression and function of the endocannabinoid system in glial cells

Paola Massi, Marta Valenti, Daniele Bolognini, Daniela Parolaro

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

In the last few years the role and significance of the glia in CNS function and pathology have been drastically reassessed. Glial cells physiology appears very different in healthy versus pathological brain and the recent identification of cannabinoid receptors and their endogenous ligands in glia has triggered a number of studies exploring the role of (endo)cannabinoid system in glia functionality and disease. (Endo)cannabinoids exert their effects in these cells directly affecting some important peculiar functions of the glia and actively promoting biochemical signals ending in a pro-survival fate for these cells. By contrast, (endo)cannabinoids induce a selective death in glia-derived tumor cells. Of special physiological and therapeutic relevance is the reported ability of glial cells during neuropathological conditions to release an increased amount of endocannabinoids and to overexpress cannabinoid receptors. This evidence has suggested that the endocannabinoids production by glial cells may constitute an endogenous defense mechanism preventing the propagation of neuroinflammation and cell damage. The present paper will review the evidence supporting the regulatory role of (endo)cannabinoids in glia function, holding in consideration their therapeutic potential as neuroprotective and/or anticancer agents.
Original languageEnglish
Pages (from-to)2289-2298
Number of pages10
JournalCurrent Pharmaceutical Design
Volume14
Issue number23
DOIs
Publication statusPublished - Aug 2008

Fingerprint

Endocannabinoids
Neuroglia
Cannabinoids
Cannabinoid Receptors
Cell Physiological Phenomena
Neuroprotective Agents
Antineoplastic Agents
Cell Survival
Pathology
Ligands

Keywords

  • animals
  • antineoplastic agents
  • central nervous system diseases
  • endocannabinoids
  • gene expression
  • humans
  • neuroglia
  • neuroprotective agents
  • receptors, cannabinoid
  • signal transduction

Cite this

Expression and function of the endocannabinoid system in glial cells. / Massi, Paola; Valenti, Marta; Bolognini, Daniele; Parolaro, Daniela.

In: Current Pharmaceutical Design, Vol. 14, No. 23, 08.2008, p. 2289-2298.

Research output: Contribution to journalArticle

Massi, P, Valenti, M, Bolognini, D & Parolaro, D 2008, 'Expression and function of the endocannabinoid system in glial cells', Current Pharmaceutical Design, vol. 14, no. 23, pp. 2289-2298. https://doi.org/10.2174/138161208785740135
Massi, Paola ; Valenti, Marta ; Bolognini, Daniele ; Parolaro, Daniela. / Expression and function of the endocannabinoid system in glial cells. In: Current Pharmaceutical Design. 2008 ; Vol. 14, No. 23. pp. 2289-2298.
@article{f825066180be47be9baa9781a2f1b899,
title = "Expression and function of the endocannabinoid system in glial cells",
abstract = "In the last few years the role and significance of the glia in CNS function and pathology have been drastically reassessed. Glial cells physiology appears very different in healthy versus pathological brain and the recent identification of cannabinoid receptors and their endogenous ligands in glia has triggered a number of studies exploring the role of (endo)cannabinoid system in glia functionality and disease. (Endo)cannabinoids exert their effects in these cells directly affecting some important peculiar functions of the glia and actively promoting biochemical signals ending in a pro-survival fate for these cells. By contrast, (endo)cannabinoids induce a selective death in glia-derived tumor cells. Of special physiological and therapeutic relevance is the reported ability of glial cells during neuropathological conditions to release an increased amount of endocannabinoids and to overexpress cannabinoid receptors. This evidence has suggested that the endocannabinoids production by glial cells may constitute an endogenous defense mechanism preventing the propagation of neuroinflammation and cell damage. The present paper will review the evidence supporting the regulatory role of (endo)cannabinoids in glia function, holding in consideration their therapeutic potential as neuroprotective and/or anticancer agents.",
keywords = "animals, antineoplastic agents, central nervous system diseases, endocannabinoids, gene expression, humans, neuroglia, neuroprotective agents, receptors, cannabinoid, signal transduction",
author = "Paola Massi and Marta Valenti and Daniele Bolognini and Daniela Parolaro",
year = "2008",
month = "8",
doi = "10.2174/138161208785740135",
language = "English",
volume = "14",
pages = "2289--2298",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "23",

}

TY - JOUR

T1 - Expression and function of the endocannabinoid system in glial cells

AU - Massi, Paola

AU - Valenti, Marta

AU - Bolognini, Daniele

AU - Parolaro, Daniela

PY - 2008/8

Y1 - 2008/8

N2 - In the last few years the role and significance of the glia in CNS function and pathology have been drastically reassessed. Glial cells physiology appears very different in healthy versus pathological brain and the recent identification of cannabinoid receptors and their endogenous ligands in glia has triggered a number of studies exploring the role of (endo)cannabinoid system in glia functionality and disease. (Endo)cannabinoids exert their effects in these cells directly affecting some important peculiar functions of the glia and actively promoting biochemical signals ending in a pro-survival fate for these cells. By contrast, (endo)cannabinoids induce a selective death in glia-derived tumor cells. Of special physiological and therapeutic relevance is the reported ability of glial cells during neuropathological conditions to release an increased amount of endocannabinoids and to overexpress cannabinoid receptors. This evidence has suggested that the endocannabinoids production by glial cells may constitute an endogenous defense mechanism preventing the propagation of neuroinflammation and cell damage. The present paper will review the evidence supporting the regulatory role of (endo)cannabinoids in glia function, holding in consideration their therapeutic potential as neuroprotective and/or anticancer agents.

AB - In the last few years the role and significance of the glia in CNS function and pathology have been drastically reassessed. Glial cells physiology appears very different in healthy versus pathological brain and the recent identification of cannabinoid receptors and their endogenous ligands in glia has triggered a number of studies exploring the role of (endo)cannabinoid system in glia functionality and disease. (Endo)cannabinoids exert their effects in these cells directly affecting some important peculiar functions of the glia and actively promoting biochemical signals ending in a pro-survival fate for these cells. By contrast, (endo)cannabinoids induce a selective death in glia-derived tumor cells. Of special physiological and therapeutic relevance is the reported ability of glial cells during neuropathological conditions to release an increased amount of endocannabinoids and to overexpress cannabinoid receptors. This evidence has suggested that the endocannabinoids production by glial cells may constitute an endogenous defense mechanism preventing the propagation of neuroinflammation and cell damage. The present paper will review the evidence supporting the regulatory role of (endo)cannabinoids in glia function, holding in consideration their therapeutic potential as neuroprotective and/or anticancer agents.

KW - animals

KW - antineoplastic agents

KW - central nervous system diseases

KW - endocannabinoids

KW - gene expression

KW - humans

KW - neuroglia

KW - neuroprotective agents

KW - receptors, cannabinoid

KW - signal transduction

U2 - 10.2174/138161208785740135

DO - 10.2174/138161208785740135

M3 - Article

VL - 14

SP - 2289

EP - 2298

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 23

ER -